Victory Capital Management’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24K Sell
14,022
-79
-0.6% -$162 ﹤0.01% 2487
2026
Q2
$34.5K Buy
+14,101
New +$32.2K ﹤0.01% 2415

Other funds holding IPSC

Victory Capital Management's IPSC Position: Q3 2026 in Review

Victory Capital Management reduced its Century Therapeutics (IPSC) stake by 0.56% in Q3 2026, selling an estimated $162 and leaving 14,022 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #2487.

Victory Capital Management first reported a position in IPSC in Q2 2026 and has held it in 2 quarters since. The position peaked at $34.5K in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Victory Capital Management held 14,022 shares of Century Therapeutics worth $24K as of Q3 2026.
  • Victory Capital Management sold 79 Century Therapeutics shares in Q3 2026, an estimated $162.
  • Century Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2487 holding.
  • Victory Capital Management first reported a position in Century Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Victory Capital Management's Century Therapeutics position peaked at $34.5K in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.